224 related articles for article (PubMed ID: 24732155)
21. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
[TBL] [Abstract][Full Text] [Related]
22. Imaging sites of infection using a 99mTc-labeled folate conjugate targeted to folate receptor positive macrophages.
Henne WA; Rothenbuhler R; Ayala-Lopez W; Xia W; Varghese B; Low PS
Mol Pharm; 2012 May; 9(5):1435-40. PubMed ID: 22468849
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and preliminary evaluation of a
Song M; Guo Z; Gao M; Shi C; Xu D; You L; Wu X; Su X; Zhuang R; Pan W; Liu T; Zhang X
Chem Biol Drug Des; 2017 May; 89(5):755-761. PubMed ID: 27910223
[TBL] [Abstract][Full Text] [Related]
24. Development of
Lodhi NA; Park JY; Hong MK; Kim YJ; Lee YS; Cheon GJ; Jeong JM
Bioorg Med Chem; 2019 May; 27(10):1925-1931. PubMed ID: 30992201
[TBL] [Abstract][Full Text] [Related]
25.
Liang L; Zhang X; Su X; Li J; Tian Y; Xue H; Xu H
J Labelled Comp Radiopharm; 2018 Feb; 61(2):54-60. PubMed ID: 29086447
[TBL] [Abstract][Full Text] [Related]
26. A novel dual-modality imaging agent targeting folate receptor of tumor for molecular imaging and fluorescence-guided surgery.
Kim MH; Kim SG; Kim DW
Ann Nucl Med; 2019 Aug; 33(8):606-616. PubMed ID: 31134434
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate.
Liang X; Sun Y; Zeng W; Liu L; Ma X; Zhao Y; Fan J
Bioorg Med Chem; 2013 Jan; 21(1):178-85. PubMed ID: 23177726
[TBL] [Abstract][Full Text] [Related]
28. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
29. Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.
Ledermann JA; Canevari S; Thigpen T
Ann Oncol; 2015 Oct; 26(10):2034-43. PubMed ID: 26063635
[TBL] [Abstract][Full Text] [Related]
30. In vivo assay of folate receptors in nonfunctional pituitary adenomas with 99mTc-folate SPECT/CT.
Galt JR; Halkar RK; Evans CO; Osman NA; LaBorde D; Fox TH; Faraj BA; Kumar K; Wang H; Oyesiku NM
J Nucl Med; 2010 Nov; 51(11):1716-23. PubMed ID: 20956474
[TBL] [Abstract][Full Text] [Related]
31. Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers.
Kumar D; Sakhare N; Das S; Kale P; Mathur A; Mirapurkar S; Muralidharan S; Chaudhari P; Mohanty B; Ballal A; Patro P
Nucl Med Biol; 2021 Feb; 93():1-10. PubMed ID: 33212346
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Evaluation of (99m)Tc-Labeled Dimeric Folic Acid for FR-Targeting.
Guo Z; Gao M; Song M; Shi C; Zhang P; Xu D; You L; Zhuang R; Su X; Liu T; Du J; Zhang X
Molecules; 2016 Jun; 21(6):. PubMed ID: 27338334
[TBL] [Abstract][Full Text] [Related]
33. Preparation and Evaluation of Novel Folate Isonitrile
Feng J; Zhang X; Ruan Q; Jiang Y; Zhang J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361705
[TBL] [Abstract][Full Text] [Related]
34. High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide.
Guertin AD; O'Neil J; Stoeck A; Reddy JA; Cristescu R; Haines BB; Hinton MC; Dorton R; Bloomfield A; Nelson M; Vetzel M; Lejnine S; Nebozhyn M; Zhang T; Loboda A; Picard KL; Schmidt EV; Dussault I; Leamon CP
Mol Cancer Ther; 2016 Aug; 15(8):1998-2008. PubMed ID: 27256377
[TBL] [Abstract][Full Text] [Related]
35. Tumor detection using folate receptor-targeted imaging agents.
Sega EI; Low PS
Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
[TBL] [Abstract][Full Text] [Related]
36. EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers.
Dosio F; Milla P; Cattel L
Curr Opin Investig Drugs; 2010 Dec; 11(12):1424-33. PubMed ID: 21154124
[TBL] [Abstract][Full Text] [Related]
37. Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lung.
Edelman MJ; Harb WA; Pal SE; Boccia RV; Kraut MJ; Bonomi P; Conley BA; Rogers JS; Messmann RA; Garon EB
J Thorac Oncol; 2012 Oct; 7(10):1618-21. PubMed ID: 22982661
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and preliminary evaluation of novel (99m)Tc-labeled folate derivative via click reaction for SPECT imaging.
Guo Z; Zhang P; Song M; Wu X; Liu C; Zhao Z; Lu J; Zhang X
Appl Radiat Isot; 2014 Sep; 91():24-30. PubMed ID: 24880914
[TBL] [Abstract][Full Text] [Related]
39. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys.
Yang JJ; Kularatne SA; Chen X; Low PS; Wang E
Mol Pharm; 2012 Feb; 9(2):310-7. PubMed ID: 22171616
[TBL] [Abstract][Full Text] [Related]
40. Folic acid conjugates for nuclear imaging of folate receptor-positive cancer.
Müller C; Schibli R
J Nucl Med; 2011 Jan; 52(1):1-4. PubMed ID: 21149477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
